PCM
PRVA icon

Prelude Capital Management’s Privia Health PRVA Stock Holding History

Prelude Capital Management’s Portfolio PRVA Stock Details PRVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-10,995
Closed -$200K – 1486
2024
Q3 		$200K Buy
+10,995
New +$210K 0.01% 1072
2024
Q2 		– Sell
-20,764
Closed -$407K – 1439
2024
Q1 		$407K Buy
+20,764
New +$439K 0.02% 729

Other funds holding PRVA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DCP
Durable Capital Partners Bethesda, Maryland $9.71B AUM 26.27% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
RF
Rubicon Founders Nashville, Tennessee $138M AUM 61.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Prelude Capital Management's PRVA Position: Q4 2024 in Review

Prelude Capital Management sold out of Privia Health (PRVA) in Q4 2024, closing a stake of 10,995 shares — an estimated $200K sold.

Prelude Capital Management first reported a position in PRVA in Q1 2024 and held it in 2 quarters. The position peaked at $407K in Q1 2024. 231 funds tracked by Wall St. Rank hold PRVA as of Q4 2024.

  • Prelude Capital Management reported no remaining Privia Health position as of Q4 2024 after selling out during the quarter.
  • Prelude Capital Management sold 10,995 Privia Health shares in Q4 2024, an estimated $200K.
  • Prelude Capital Management first reported a position in Privia Health in Q1 2024 and held it in 2 quarters.
  • Prelude Capital Management's Privia Health position peaked at $407K in Q1 2024.
  • 231 funds tracked by Wall St. Rank held Privia Health as of Q4 2024.

Based on Prelude Capital Management's 13F filing for Q4 2024, filed 14 Feb 2025.